| The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors SL Dickson, RH Shirazi, C Hansson, F Bergquist, H Nissbrandt, ... Journal of Neuroscience 32 (14), 4812-4820, 2012 | 363 | 2012 |
| l‐DOPA‐induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson’s disease: temporal and quantitative relationship to the expression of … HS Lindgren, DR Andersson, S Lagerkvist, H Nissbrandt, MA Cenci Journal of neurochemistry 112 (6), 1465-1476, 2010 | 277 | 2010 |
| The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine O Blomqvist, JA Engel, H Nissbrandt, B Söderpalm European journal of pharmacology 249 (2), 207-213, 1993 | 218 | 1993 |
| Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism V Francardo, F Bez, T Wieloch, H Nissbrandt, K Ruscher, MA Cenci Brain 137 (7), 1998-2014, 2014 | 204 | 2014 |
| Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease V Francardo, A Recchia, N Popovic, D Andersson, H Nissbrandt, ... Neurobiology of disease 42 (3), 327-340, 2011 | 186 | 2011 |
| The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease CM Lill, A Rengmark, L Pihlstrøm, I Fogh, A Shatunov, PM Sleiman, ... Alzheimer's & Dementia 11 (12), 1407-1416, 2015 | 162 | 2015 |
| Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease M von Otter, S Landgren, S Nilsson, D Celojevic, P Bergström, ... BMC medical genetics 11, 1-9, 2010 | 137 | 2010 |
| GABAB‐Receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra G Engberg, T Kling‐Petersen, H Nissbrandt Synapse 15 (3), 229-238, 1993 | 119 | 1993 |
| Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder M Landén, H Nissbrandt, C Allgulander, K Sörvik, C Ysander, E Eriksson Neuropsychopharmacology 32 (1), 153-161, 2007 | 115 | 2007 |
| Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease L Pihlstrøm, G Axelsson, KA Bjørnarå, N Dizdar, C Fardell, L Forsgren, ... Neurobiology of aging 34 (6), 1708. e7-1708. e13, 2013 | 108 | 2013 |
| GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality RH Anderberg, JE Richard, C Hansson, H Nissbrandt, F Bergquist, ... Psychoneuroendocrinology 65, 54-66, 2016 | 104 | 2016 |
| Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacta, pars reticulata, and striatum H Nissbrandt, E Sundström, G Jonsson, S Hjorth, A Carlsson Journal of neurochemistry 52 (4), 1170-1182, 1989 | 103 | 1989 |
| The stomach-derived hormone ghrelin increases impulsive behavior RH Anderberg, C Hansson, M Fenander, JE Richard, SL Dickson, ... Neuropsychopharmacology 41 (5), 1199-1209, 2016 | 101 | 2016 |
| Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease A Håkansson, L Westberg, S Nilsson, S Buervenich, A Carmine, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 133 …, 2005 | 101 | 2005 |
| Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod F Bergquist, HN Shahabi, H Nissbrandt Brain research 973 (1), 81-91, 2003 | 90 | 2003 |
| PITX3 polymorphism is associated with early onset Parkinson's disease O Bergman, A Håkansson, L Westberg, K Nordenström, AC Belin, ... Neurobiology of aging 31 (1), 114-117, 2010 | 89 | 2010 |
| Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux H Nissbrandt, A Elverfors, G Engberg Synapse 17 (4), 217-224, 1994 | 87 | 1994 |
| Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain E Eriksson, G Engberg, O Bing, H Nissbrandt Neuropsychopharmacology 20 (3), 287-296, 1999 | 80 | 1999 |
| Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease–a multicenter study M von Otter, P Bergström, A Quattrone, EV De Marco, G Annesi, ... BMC medical genetics 15 (1), 1-13, 2014 | 79 | 2014 |
| Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine … G Engberg, T Elebring, H Nissbrandt Journal of Pharmacology and Experimental Therapeutics 259 (2), 841-847, 1991 | 77 | 1991 |
